4
Changes in Ownership
Propanc Biopharma, Inc. Filed Acc 0001354488-12-004546
Chief Executive Officer bought 250,000 shares at $0.20 ($50,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nathanielsz James Andrew Chief Executive Officer | 2012-08-23 | Purchase | −250,000 | $0.20 | $50,000 | 9,782,261 | I |
| Open-market purchases · 250,000 sh · avg $0.20 · $50,000 | |||||||
Loading xslF345X03/issuerdirect_section16.xml…